Updated FDA Recognition of CLSI Breakpoints (JCM ed.)
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to Cart failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Please try again
Unfollow podcast failed
Please try again
Updated FDA Recognition of CLSI Breakpoints (JCM ed.)
-
Narrated by:
-
By:
About this listen
Oversight and guidance for performing antibiotic susceptibility testing can be bewildering. There is an alphabet soup of agencies and bodies involved: FDA, CLSI, and USCAST, to name a few here in the US. How does the Food and Drug Administration, which has regulatory authority over AST, work with a nimble group like the Clinical Laboratory Standards Institute?
Guests:
- Romney Humphries, Ph.D., D(ABMM), M(ASCP)
- Patricia Simner, Ph.D., D(ABMM)
- Major updates to FDA-recognized Clinical and Laboratory Standards Institute breakpoints are a win for the fight against antimicrobial resistance
- Join ASM for up to 50% off the publication fees when you publish in JCM or any of the ASM journals.
- Attend ASM Microbe
This episode of Editors in Conversation is brought to you by the Journal of Clinical Microbiology and hosted by JCM Editor in Chief, Alex McAdam and Dr. Elli Theel. JCM is available at https://jcm.asm.org and on https://twitter.com/JClinMicro.
Visit journals.asm.org/journal/jcm to read articles and/or submit a manuscript.
Follow JCM on Twitter/𝕏 via @JClinMicro
No reviews yet